BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6162258)

  • 1. [Toxicity of high-dose bleomycin administered by continuous infusion].
    Fornasiero A; Daniele O; Paccagnella A; Fosser V; Cartei G; Ferrazzi E; Fiorentino M
    Tumori; 1980 Oct; 66(5):607-13. PubMed ID: 6162258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of poor prognosis nonseminomatous testicular cancer with a "high-dose" platinum combination chemotherapy regimen.
    Ozols RF; Deisseroth AB; Javadpour N; Barlock A; Messerschmidt GL; Young RC
    Cancer; 1983 May; 51(10):1803-7. PubMed ID: 6187426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vinblastine, actinomycin D, bleomycin, cyclophosphamide and cis-platinum for advanced germ cell testis tumors: Brazilian experience.
    Srougi M; Simon SD; de Góes GM
    J Urol; 1985 Jul; 134(1):65-9. PubMed ID: 2409300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential combination chemotherapy with vinblastine-bleomycin and doxorubicin-cis-dichlorodiammineplatinum(II) in disseminated nonseminomatous testicular cancer.
    Scheulen ME; Seeber S; Schilcher RB; Meier CR; Schmidt CG
    Cancer Treat Rep; 1980; 64(4-5):599-609. PubMed ID: 6159077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vinblastine, intermittent bleomycin, and single-dose cis-dichlorodiammineplatinum(II) in the management of stge III testicular cancer.
    Bosl GJ; Kwong R; Lange PH; Fraley EE; Kennedy BJ
    Cancer Treat Rep; 1980; 64(2-3):331-4. PubMed ID: 6157467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vinblastine plus bleomycin continuous infusion chemotherapy of stage III testicular carcinomas.
    Monfardini S; Fossati V; Pizzocaro G; Villa E
    Tumori; 1981; 67(2):117-23. PubMed ID: 6167041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy for disseminated testicular cancer.
    Einhorn LH; Donohue JP
    Urol Clin North Am; 1977 Oct; 4(3):407-26. PubMed ID: 76358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vinblastine, infusion, bleomycin, and cis-dichlorodiammine-platinum chemotherapy in metastatic melanoma.
    Nathanson L; Kaufman SD; Carey RW
    Cancer; 1981 Sep; 48(6):1290-4. PubMed ID: 6168365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination chemotherapy with cis-diammine-dichloro-platinum, vinblastine, and bleomycin in advanced testicular non-seminoma.
    Stoter G; Sleijfer DT; Vendrik CP; Schraffordt Koops H; Struyvenberg A; Van Oosterom AT; Brouwers TM; Pinedo HM
    Lancet; 1979 May; 1(8123):941-5. PubMed ID: 87614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced platelet survival following chemotherapy with vinblastine, bleomycin and cis-platinum for testicular teratoma.
    Rees GJ; Slade RR; Hopes P
    Eur J Cancer Clin Oncol; 1982 Nov; 18(11):1125-9. PubMed ID: 6186497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant vinblastine, actinomycin D, bleomycin, cyclophosphamide and cis-platinum chemotherapy regimen with and without maintenance in patients with resected stage IIB testis cancer.
    Vugrin D; Whitmore WF; Herr H; Sogani P; Golbey RB
    J Urol; 1982 Oct; 128(4):715-7. PubMed ID: 6183456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variables for predicting serious toxicity (vinblastine dose, performance status, and prior therapeutic experience): chemotherapy for metastatic testicular cancer with cis-dichlorodiammineplatinum(II), vinblastine, and bleomycin.
    Krikorian JG; Daniels JR; Brown BW; Hu MS
    Cancer Treat Rep; 1978 Oct; 62(10):1455-63. PubMed ID: 81719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-response and dose-survival advantage for high versus low-dose cisplatin combined with vinblastine and bleomycin in disseminated testicular cancer. A Southwest Oncology Group study.
    Samson MK; Rivkin SE; Jones SE; Costanzi JJ; LoBuglio AF; Stephens RL; Gehan EA; Cummings GD
    Cancer; 1984 Mar; 53(5):1029-35. PubMed ID: 6198064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vinblastine, actinomycin D, bleomycin, cyclophosphamide and cis-platinum combination chemotherapy in metastatic testis cancer--a 1-year program.
    Vugrin D; Whitmore WF; Golbey RB
    J Urol; 1982 Dec; 128(6):1205-8. PubMed ID: 6185697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multimodal treatment of advanced testicular tumor with radical reductive surgery and multisequential chemotherapy with cis platinum, bleomycin, vinblastine, vincristine and actinomycin D.
    Merrin C; Beckley S; Takita H
    J Urol; 1978 Jul; 120(1):73-6. PubMed ID: 78991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of prior exposure to bleomycin on the incidence of pulmonary toxicities in a group of patients with disseminated testicular carcinomas.
    Crooke ST; Einhorn LH; Comis RL; D'Aoust JC; Prestayko AW
    Med Pediatr Oncol; 1978; 5(1):93-8. PubMed ID: 85253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of disseminated testicular tumors with combination of cis-platinum, vinblastine, bleomycin and actinomycin D.
    Roth A; Kolarić K
    Oncology; 1985; 42(4):248-52. PubMed ID: 2409495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of corticosteroid administration on bleomycin lung toxicity.
    Jensen JL; Goel R; Venner PM
    Cancer; 1990 Mar; 65(6):1291-7. PubMed ID: 1689606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low toxicity with continuous infusion of high-dose bleomycin in poor prognostic testicular cancer.
    Gerson R; Tellez Bernal E; Lazaro Leon M; Sanchez Forgach E; Garcia Irigoyen C; Gutierrez Godinez F; Garcia Gonzalez H
    Am J Clin Oncol; 1993 Aug; 16(4):323-6. PubMed ID: 7687091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vinblastine (VLB), bleomycin (BLEO), cis-diamminedichloroplatinum (DDP) in disseminated extragonadal germ cell tumors. A Southwest Oncology Group Study.
    Feun LG; Samson MK; Stephens RL
    Cancer; 1980 May; 45(10):2543-9. PubMed ID: 6155194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.